TOV-21G Cells
USUSD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | TOV-21G is a human epithelial ovarian cancer cell line derived from a primary clear cell carcinoma tumor obtained from an adult patient who had not received prior chemotherapy or radiation treatment. The cell line was established as part of a panel of spontaneously immortalized ovarian cancer models that retain many biological characteristics of the original tumors from which they were derived. TOV-21G grows as an adherent epithelial monolayer in culture and exhibits morphological and molecular features consistent with clear cell ovarian carcinoma, a distinct histological subtype of epithelial ovarian cancer characterized by aggressive clinical behavior and unique molecular alterations. Molecular and genomic analyses of ovarian cancer cell line panels have demonstrated that TOV-21G contains alterations in genes and pathways commonly implicated in ovarian tumorigenesis, including mutations affecting tumor suppressor and cell cycle regulatory pathways. Comparative gene expression profiling using high-density microarrays has shown that TOV-21G displays transcriptional patterns that clearly distinguish it from normal ovarian surface epithelial cells and align more closely with profiles observed in aggressive epithelial ovarian tumors. These analyses highlight dysregulation of numerous genes involved in proliferation, cellular signaling, and tumor progression, supporting the relevance of TOV-21G as a model for studying ovarian cancer biology. Functional studies using TOV-21G have demonstrated pronounced neoplastic properties, including anchorage-independent growth, invasive behavior, and tumorigenic potential in experimental systems. Chromosomal and genomic investigations further indicate that introduction of specific normal chromosomes, such as chromosomes 6 or 18, can suppress aspects of the malignant phenotype, suggesting the presence of tumor suppressor loci affecting ovarian cancer progression. These properties make TOV-21G a valuable experimental model for investigating mechanisms of ovarian carcinogenesis, tumor suppressor gene function, and the evaluation of targeted therapeutic strategies for clear cell ovarian cancer. |
|---|---|
| 生物體 | Human |
| 組織 | Ovary |
| 疾病 | Clear cell adenocarcinoma of the ovary |
| 同義詞 | TOV-21g, TOV21G, TOV21 |
特徵
| 年齡 | 62 years |
|---|---|
| 性別 | Female |
| 族裔 | Caucasian |
| 形態學 | epithelial |
| 生長特性 | Adherent |
監管數據
| 引用 | TOV-21G (Cytion catalog number 305892) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_3613 |
生物分子資料
| 突變譜 | Mutation: p.Gly13Cys, Heterozygous; Mutation: p.His1047Tyr, Heterozygous; Mutation: p.Lys267Argfs*9, Heterozygous |
|---|
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 15% FBS |
| 解離試劑 | Accutase |
| 倍增時間 | 1.5 days ; 27 hours ; 30.62 hours |
| 播種密度 | 1 to 3 x 104 cells/cm2 |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305892-090226 | 分析證明書 | 05. Mar. 2026 | 305892 |